Altitude Crest Partners’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-209,613	Closed	-$4.3M	–	11
2024 Q1	$4.3M	Buy	+209,613	New	+$4.3M	1.84%	19